FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
abcnews - The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol
AI Summary: The FDA approved a first‑of‑its‑kind oral cholesterol medication intended to lower LDL in high‑risk patients, offering a cheaper, pill‑based alternative to costly PCSK9 injections. Regulators cleared the treatment after reviewing trial data showing substantial LDL reductions, positioning it as a potentially more accessible option for long‑term cardiovascular risk management.
Related Stories
FDA clears AstraZeneca’s new blood-pressure drug baxdrostat / 1 month
Denali drug receives accelerated approval for rare CNS indication / 3 months
Orca Bio allogeneic cell therapy wins landmark FDA approval / 12 days
FDA approves Merck’s once‑daily two‑drug HIV pill, shaking up market / 2 months
Analysis finds anti-amyloid Alzheimer's drugs lack meaningful benefit / 3 months
FDA clears first once‑weekly basal insulin for Type 2 diabetes / 3 months
FDA approves Rocket Pharma gene therapy for ultra‑rare immune disorder / 3 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Avian Influenza, Public Health, Venture Capital, Research Funding and look for the RSS link.
StackHealth Time Machine